NEW YORK (GenomeWeb) – NanoString Technologies preannounced its fourth quarter and full-year 2014 revenues after the close of the market on Thursday.

For the fourth quarter, the Seattle-based firm said that revenues are anticipated to be in the range of $15 million to $16 million, which would represent an increase of 48 percent to 58 percent year over year from $10.1 million in revenues during Q4 2013. The consensus analyst estimate for revenues in the quarter is $15 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.